GeoVax Labs Inc (GOVX)

[remind2]

GOVX: Q3, 2016, due next week. Cash may be the issue.


The delay in Zika Funding and the push back of the HIV trial to December form June may have impacted the bottom line for GOVX in regard to Federal grant money.

Some investors or maybe a Fund may be concerned about this issue showing up in the upcoming Q3, 2016 report.

Likely the stock may be weak until the Q3 numbers are in.


Q2 link: Showed some cash drain that may not have been replaced:
http://www.geovax.com/component/easyblog/entry/2016/08/05/geovax-reports-2016-second-quarter-financial-results-and-provides-corporate-update.html?Itemid=101